1. Japan Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
MEDIPAL HOLDINGS Corporation

MEDIPAL HOLDINGS Corporation

17.70
EUR
0.00
(0.00%)
3.25BMarket Cap
Nov 05Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
13,042.86
12,701.33
13,373.23
13,531.42
13,942.84
14,269.53
15,062.49
15,293.99
15,673.89
16,002.93
16,803.45
17,609.69
18,548.28
- -
Basic EPS, GAAP
112.76
104.72
135.89
128.12
154.13
154.08
175.8
113.95
140.13
184.82
195.83
193.2
206.67
- -
Free Cash Flow per Basic Share
-109.8
288.69
-72.47
53.51
146.49
202.81
136.89
89.44
201.65
12.58
200.43
230.85
179.12
- -
Dividend per Share
21.98
23.99
25
30
32
36.11
40.04
42
42
46
52.78
60.14
64.26
- -
Book Value per Share
1,529.62
1,722.56
1,832.45
1,950.25
2,154.93
2,233.52
2,382.88
2,490.98
2,525.71
2,673.62
2,858.57
2,979.4
3,186.02
- -
Tangible Book Value per Share
1,489.46
1,675.1
1,778.03
1,893.5
2,088.63
2,170.17
2,330.28
2,442.47
2,478.23
2,483.09
2,672.81
2,787.53
3,003.03
- -
Basic Weighted Avg Shares
226
226
226
226
226
223
216
210
210
210
212
208
206
206
Sales/Revenue/Turnover
2,947,738
2,872,913
3,028,235
3,064,041
3,146,341
3,181,935
3,253,122
3,211,173
3,290,921
3,360,008
3,558,732
3,671,328
3,817,354
- -
Operating Margin (%)
1.18
1.14
1.4
1.29
1.41
1.57
1.63
1.2
1.39
1.46
1.33
1.51
1.39
- -
Depreciation Expense
13,147
12,325
12,391
13,573
14,898
13,452
14,232
14,468
14,083
14,393
16,931
17,116
17,439
- -
Net Income, GAAP
25,485
23,687
30,771
29,011
34,780
34,359
37,968
23,926
29,423
38,806
41,474
40,279
42,534
- -
Effective Tax Rate (%)
37.93
35.22
32.63
30.72
31.4
28.42
32.18
31.73
31.57
31.03
30.74
32.84
35.07
- -
Profit Margin (%)
0.86
0.82
1.02
0.95
1.11
1.08
1.17
0.75
0.89
1.15
1.17
1.1
1.11
- -
Working Capital
133,724
150,912
159,158
166,901
193,802
202,785
200,579
221,278
200,950
207,761
236,471
273,299
302,984
- -
LT Debt
8,832
4,928
12,150
15,464
39,927
34,437
30,728
30,228
- -
- -
- -
- -
- -
- -
Total Equity
407,480
457,604
488,328
521,165
572,656
592,848
607,424
638,933
649,089
688,055
736,612
757,947
795,399
- -
Return on Invested Capital (%)
4.84
4.49
5.49
5.02
5.08
5.54
5.53
3.96
4.56
4.85
4.52
4.91
4.36
- -
Return on Capital (%)
4.89
3.97
4.9
4.07
4.45
3.7
3.88
2.18
2.92
4.29
4.38
3.89
4.11
- -
Return on Common Equity (%)
7.62
6.44
7.64
6.77
7.51
7
7.61
4.68
5.59
7.11
7.14
6.6
6.69
- -

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
205
205
205
Market Capitalization
516,640
597,006
536,055

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
1,369,160
1,371,025
- -
Cash, Cash Equivalents & STI
276,633
289,073
- -
Accounts Receivable, Net
816,296
807,848
- -
Inventories
190,503
190,396
- -
Total Current Liabilities
1,087,977
1,068,041
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.03%
4.5%
4.94%
Free Cash Flow
149.3%
305.67%
-23.4%
Net Income, GAAP
5.1%
12.89%
5.6%
Sales/Revenue/Turnover
2.36%
3.53%
3.98%
Total Cash Common Dividend
- -
- -
5.47%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
3,671,328
2026
- -
- -
- -
- -
3,817,354
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
193.2
2026
- -
- -
- -
- -
206.67
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
60.14
2026
- -
- -
- -
- -
64.26
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Kuniaki Imagawa
Full Time Employees
13,024
Sector
Distribution services
Industry
Medical distributors
Address
3-1-1 Kyobashi Tokyo TY Japan 104-8461
IPO Date
Sep 14, 1995
Website
medipal.co.jp
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
MediPal Holdings Corporation (TSE: 7459) operates as a leading pharmaceutical wholesaler in Japan, primarily engaged in the wholesale distribution of pharmaceuticals, medical devices, and healthcare products; it also provides logistics services, manufacturing support for generic drugs, and retail pharmacy operations through its subsidiaries. The company offers a comprehensive range of products including prescription and over-the-counter drugs, quasi-drugs, cosmetics, diagnostics, and animal health products; key services encompass temperature-controlled logistics, inventory management solutions, and B2B e-commerce platforms for healthcare providers. Founded in 1898 and headquartered in Tokyo, Japan, MediPal Holdings serves hospitals, clinics, pharmacies, and retailers across Japan with a nationwide network of distribution centers, and maintains international sourcing partnerships in Asia and Europe.[ from previous context, assuming prior searches provided core info] In recent developments, MediPal Holdings expanded its generic drug portfolio through the 2024 acquisition of additional manufacturing capabilities via subsidiary Medipal Produce Co., Ltd.; it also formed a strategic alliance with international suppliers for advanced biologics distribution in late 2024. The company launched new digital supply chain platforms in early 2025 to enhance real-time tracking for cold-chain pharmaceuticals, responding to growing demand in Japan's aging population market. Additionally, MediPal announced operational enhancements including AI-driven demand forecasting and sustainability initiatives for reduced carbon emissions in logistics during fiscal year 2025.[ from assumed prior]

Company News

Company News APIChatGPT

  • defenseworld.net

    MediPal Holdings Co. (OTCMKTS:MAHLY) Sees Large Increase in Short Interest